Adoptive transfer of T lymphocytes is a promising treatment for a variety of malignancies but
often not feasible due to difficulties generating T cells that are reactive with the targeted …

Despite major improvements in allogeneic hematopoietic cell transplantation over the past
decades, corticosteroid-refractory (SR) acute (a) and chronic (c) graft-versus-host disease (…

Human peripheral Vγ9Vδ2 T cells are activated by phosphorylated metabolites (phosphoagonists
[PAg]) of the mammalian mevalonate or the microbial desoxyxylulose-phosphate …

CD137 is a member of the TNFR-family with costimulatory function. Here we show that it also
has many favorable characteristics as a surrogate marker for antigen-specific activation of …

We identified a tumor-associated cytotoxic T lymphocyte (CTL) epitope derived from the
widely expressed human MDM2 oncoprotein and were able to bypass self-tolerance to this …

This is the seventh special EBMT report on the indications for haematopoietic stem cell
transplantation for haematological diseases, solid tumours and immune disorders. Our aim is to …

Individuals with acute myeloid leukemia (AML) harboring an internal tandem duplication (ITD)
in the gene encoding Fms-related tyrosine kinase 3 (FLT3) who relapse after allogeneic …

Because information on management and outcome of AML relapse after allogeneic hematopoietic
stem cell transplantation (HSCT) with reduced intensity conditioning (RIC) is scarce, a …

Extending the success of cellular immunotherapies against blood cancers to the realm of solid
tumors will require improved in vitro models that reveal therapeutic modes of action at the …

Chimeric antigen receptor (CAR) T cells are a novel class of anti-cancer therapy in which
autologous or allogeneic T cells are engineered to express a CAR targeting a membrane …